Relationship of human papilloma virus multiple genotype infection with patient’s age and type of cervical lesion

Purpose of investigation: To document the prevalence of infection by multiple genotypes of the human papilloma virus (HPV) in patients with cervical pathology in a study population, and to determine the relationship between multiple genotype infection, age of the patient, and the type of cervical pathology. Materials and Methods: Prospective, cross-sectional descriptive study. A total of 1,007 patients were recruited among women seen at the cervical pathology clinic of Sant Joan de Déu University Hospital in Barcelona (Spain) between January 2003 and March 2011. Statistical analyses were done with SPSS v.19 software. Differences between groups were considered statistically significant at p < 0.05. Results: There was 28.3% of the women (286 cases) that were infected by multiple HPV genotypes. The mean number of genotypes identified was 2.52 (range 2 to 8). Mean age of the patients with multiple genotype infection was 32.31 years, and mean age of the patients with single genotype infection was 37.27 years (p < 0.001). The prevalence of infection by multiple HPV genotypes was 28% in patients with cervical intraepithelial neoplasia grade 1 (CIN 1) and 33% in patients with grade CIN 2-3 lesions, and both prevalence rates were significantly higher than in patients with carcinoma (20%) (p=0.03). Conclusions: In the present study population the authors found no evidence of higher prevalence of multiple HPV genotype infection in women with carcinoma. Age of women with multiple infection was lower than those with single infection.

Human papillomavirus infection; Cervical cancer; Cervical intraepithelial neoplasia; Grade 1, 2, 3; Multiple infection.

[1] Clifford G.M., Smith J.S., Plummer M., Muñoz N., Francdeschi S.: “Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis”. Br. J. Cancer, 2003, 88, 63.

[2] De Sanjosé S., Diaz M., Castellsagué X., Clifford G., Bruni L., Miñox N., et al.: “Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis”. Lancet Infect. Dis., 2007, 7, 453.

[3] De Villiers E.M., Fauquet C., Borker T.R., Bernard H.U., zur Hausen H.: “Classification of papillomaviruses”. Virology, 2004, 324, 17.

[4] Castellsagué X., San Martín M., González A., Casado M.A.: “Epidemiología de las lesiones precancerosas y verrugas genitales asociadas a infección por virus de papiloma humano en España”. Prog. Obstet. Ginecol., 2010, 53, 81.

[5] De Sanjosé S., Quint W., Alemany L., Geraets D., Klaustermeier J., Lloveras B., et al.: “Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional Worldwide study”. Lancet Oncol., 2010, 11, 1048.

[6] Castellsagué X.: “Natural history and epidemiology of HPV infection and cervical cancer”. Gynec. Oncol., 2008, 110, S4.

[7] Schiffman M., Herrero R., Desalle R., Hildesheim A., Wacholder S., Rodriguez A.C., et al.: “The carcinogenicity of human papillomavirus types reflects viral evolution”. Virology, 2005, 337, 76.

[8] Pista A., Oliveira A., Verdasca N., Ribeiro F.: “Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women”. Clin. Microbiol. Infect., 2010, 17, 941.

[9] Carozzi F., Ronco G., Gillio-Tos A., De Marco L., Del Mistro A., Girlando S., et al.: “Concurrent infections with multiples human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study”. Eur. J. Cancer, 2012, 48, 1633.

[10] Spinillo A., Dal Bello B., Gardella B., Roccio M., Diletta M., Silini E.: “Multiple human papillomavirus infection and high grade cervical intrapithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions”. Gynecol. Oncol., 2009, 113, 115.

[11] Dal Bello B., Spinillo A., Alverizzi P., Cesari S., Gardella B., D’Ambrosio G., et al.: “Cervical infections by multiple human papillomavirus (HPV) genotypes: prevalence and impact on the risk of precancerous epithelial lesions”. J. Med. Virology, 2009, 81, 703.

[12] Nielsen A., Krüger S., Munk C., Iftner T.: “Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women”. Sex Trans. Dis., 2008, 35, 276.

[13] Watari H., Michimata R., Yasuda M., Ishizu A., Tomaru U., Xiong Y., et al.: “High prevalence of multiple human papillomavirus infection in Japanese patients with invasive uterine cervical cancer”. Pathobiology, 2011, 78, 220. doi: 10.1159/000326770. Epub 2011 Jul 19.

[14] Mazarico E., González-Bosquet E.: “Prevalence of infection by different genotypes of human papillomavirus in women with cervical pathology”. Gynec. Oncol., 2012, 125, 181.

[15] Gargiulo F., De Francesco M.A., Schreiber C., Ciravolo G., Salinaro F., Vallomcini B., et al.: “Prevalence and distribution of single and multiples HPV infections in cytologically abnormal cervical samples from Italian women”. Virus Res., 2007, 125, 176.

[16] Cuschieri K.S., Cubie H.A., Whitley M.W., Seagar A.L., Arends M. J., Moore G., et al.: “Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population”. J. Clin. Pathol., 2004, 57, 68.

[17] Chaturvedi A., Katki H., Hildesheim A., Rodríguez A.C., Quint W., Schiffman M., et al.: “Human papillomavirus infection with multiples types: pattern of coinfection and risk of cervical disease”. J. Inf. Dis., 2011, 203, 910.

[18] Wetzensen N., Schiffman M., Dunn T., Zunna R., Gold M., Allen R., et al.: “Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants”. Int. J. Cancer, 2009, 125, 2151.

[19] Rousseau M.C., Villa L., Costa M.C., Abrahamowicz M., Rohan T., Franco E.: “Occurrence of cervical onfection with multiples human papillomavirus types is associated with age and cytologic abnormalities”. Sex. Trans. Dis., 2003, 39, 581.

[20] Selva L., Gonzalez-Bosquet E., Rodriguez-Plata M., Esteva C., Suñol M., Muñoz Álmagro C.: “Detection of human papillomavirus infection in women attending a colposcopy clinic”. Diagn. Mic. Infec. Dis., 2009, 64, 416.

[21] World Health Organization: “Summary report on HPV and cervical cancer statistics in Spain”. Information centre on HPV and cervical cancer, 2007. Available at: http://www.who.int/hpvcentre/statistics

[22] González-Bosquet E., Muñoz Almagro M., Mora I., Suñol M., Callejo J., Lailla J.M.: “Prevalence of human papilloma virus infection of the uterine cervix in women with abnormal cervical cytology”. Eur. J. Gynaecol. Oncol., 2006, 27, 135.

[23] González-Bosquet E., Cortes X., Jiménez M., López N.: “Papel de la determinación del HPV en el screening del cáncer de cérvix”. Ginecol. Obstet. Clin., 2002, 3, 129.

[24] González-Bosquet E., Esteva C., Muñoz-Almagro C., Ferrer P., Pérez M., Lailla J.M.: “Identification of vaccine human papillomavirus genotypes in squamous intraepitelial lesions (CIN2-3)”. Gynec. Oncol., 2008, 111, 9.

[25] Martin P., Kilany L., García D., López-García A., Martín-Azaña M. J., Abraira V., et al.: “Human papillomavirus genotype distribution in Madrid and correlation with cytological data”. BMC Infec. Dis., 2011, 11, 316.

[26] Muñoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V., et al.: “Epidemiologic classification of human papillomavirus types associated with cervical cancer”. N. Engl. J. Med., 2003, 348, 518.

[27] van der Graaf Y., Molijn A., Doornewaard H., Quint W., van Doorn L.J., van den Tweel J.: “Human papillomavirus and the long-term risk of cervical neoplasia”. Am. J. Epidemiol., 2002, 156, 158.